Ang IV treatment dose-dependently attenuated left ventricular dysfunction and remodeling in a mouse model of diabetic cardiomyopathy, and the mechanism involved stimulation of AT4R, suppression of FoxO1 nuclear translocation, and inhibition of FoxO1-mediated overactive autophagy. The gene discussed is FOXO1; the disease is diabetic cardiomyopathy.